secwatch.observer — SEC 8-K summary
======================================

Issuer:     DYADIC INTERNATIONAL INC (DYAI)
CIK:        0001213809
Form:       8-K
Filed at:   2025-03-20T23:59:59+00:00
Accession:  0001437749-25-008493
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dyadic receives $4.5M CEPI grant for C1 fungus-based vaccine development
------------------------------------------------------------------------

- CEPI awards $4.5M to non-profit FBS for proof-of-concept using Dyadic's C1 fungus to produce vaccine antigens.
- Goal: reduce vaccine production and release time to 35 days, versus 4-6 months for mammalian cell lines.
- Project will compare SARS-CoV-2 spike protein produced in C1 vs. mammalian cells for structure and immunogenicity.
- Technology aims to enable faster, scalable, and affordable vaccine manufacturing for pandemic response (100 Days Mission).
- Dyadic's CEO notes support for global health security and One Health approach.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1213809/000143774925008493/0001437749-25-008493-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1213809/000143774925008493/dyai20250319_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-008493

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer